08:38:41 EST Thu 14 Nov 2019
Enter Symbol
or Name

Login ID:
ICC International Cannabis Corp
Symbol WRLD
Shares Issued 363,828,833
Close 2019-05-27 U$ 0.215
Recent Sedar Documents

ICC Int'l enters LOI to acquire Agraflora's Farma Swiss

2019-05-28 02:38 ET - News Release

Also News Release (C-AGRA) Agraflora Organics International Inc

Mr. David Shpilt of ICC International reports


ICC International Cannabis Corp. has entered into a binding letter of intent with Agraflora Organics International Inc. to acquire 100 per cent of Agraflora's Colombian pharmacy operation, Farma Swiss SAS.

The agreement provides International Cannabis with a coveted Latin American brick-and-mortar presence, as well as existing high-profile commercial agreement, further augmenting the company's THC (tetrahydrocannabinol)/CBD (cannabidiol) cultivation capabilities and robust logistical infrastructure. ICC's addition of a premier downstream Colombian asset thus conceives a compliant and secure platform for the distribution of medical cannabis and cannabinoid-derived products within Colombia.

It is anticipated that ICC will deploy a custom-made pharmacy compound strategy, originating with its inaugural Farma Swiss Colombian location.

Farma Swiss operates a licensed pharmacy, strategically situated within a high-traffic, commercial neighbourhood of Medellin, Colombia. Farma Swiss's fully licensed brick-and-mortar pharmacy operation is equipped with the following ancillary, value-added services:

  • Inbound prescription call centre, augmented by advanced supply chain and CRM software suites;
  • Domestic delivery service, providing local clientele with a vast array of medical pharmaceutical and over-the-counter (OTC) products;
  • On-site health-related services and consulting;
  • Proposed cannabinoid education and doctor detailing staging ground;
  • Virtual channel capabilities.

David Shpilt, chief executive officer of International Cannabis, stated: "The proposed acquisition of Farma Swiss represents yet another material development within the Latin American theatre for ICC, affording us the opportunity to further leverage our first-mover advantage within the Colombian medical cannabis market by directly servicing more than five million potential patients within the country.

"By integrating Farma Swiss's intuitive pharmacy platform with our 13-hectare cannabis centre of excellence and a pre-eminent catalogue of native Colombian cannabis genetics, ICC will continue to solidify its leadership position within Colombia's [highly] competitive medical cannabis marketplace, while streamlining patients access to our unique formulations."

ICC's acquisition of Farma Swiss augments recently concluded commercial arrangements between Agraflora and ICC, completing the companies' symbiotic vertically integrated global cannabis mandates:

  • Five-year-term offtake agreement whereby ICC may purchase up to 100 million grams of premium dried cannabis flower from Agraflora's Delta greenhouse complex;
  • Agraflora's assignment of its library of 20 unique Colombian cannabis genetics to International Cannabis, including prominent THC and CBD varietals, such as:
    • Caucana;
    • Purpura;
    • Medellin gold;
    • Maroc.

Brandon Boddy, chairman and chief executive officer of Agraflora, noted: "This strategic transaction further crystallizes our alliance with ICC with regards [to] our collaborative pursuit of the burgeoning global cannabis trade. Monetizing of our flagship pharmacy operation to a trusted ally permits us to streamline our international cannabis operations while focusing on the continued retrofit of our world-class greenhouse complex in Delta, B.C.

"We are excited to hereby increase our shareholdings in ICC as they continue to execute upon their international business mandate and embark upon realizing material cash flows."

International Cannabis also announces that the company is actively investigating complementary pharmacy-related assets within Colombia that may serve as synergistic accompaniments to its acquisition of Farma Swiss. Further details will be provided in due course as due diligence progresses.

As per the terms of the agreement, International Cannabis will issue Agraflora such number of common shares in the capital of ICC that is equal to $250,000 based upon the five-day variable weighted-average price of ICC's common shares for the five trading sessions prior to the announcement of the agreement.

About Agraflora Organics International Inc.

Agraflora Organics International is a growth-oriented and diversified company focused on the international cannabis industry. It owns an indoor cultivation operation in London, Ont., and is a joint venture partner in Propagation Service Canada and its large-scale 2.2-million-square-foot greenhouse complex in Delta, B.C. The company has a successful record of creating shareholder value and is actively pursuing other opportunities within the cannabis industry.

About ICC International Cannabis Corp.

ICC International Cannabis, through its subsidiaries, has operating assets and is developing a world-class platform for cultivation, extraction, formulation and distribution across the globe in the United Kingdom, Denmark, Poland, Switzerland, Germany, Macedonia, Bulgaria, Serbia, Croatia, Greece, Italy, Portugal, Malta, Colombia, Argentina, Australia, South Africa and Lesotho.

We seek Safe Harbor.

© 2019 Canjex Publishing Ltd. All rights reserved.